PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 96 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $149,000 | +2.8% | 58,100 | 0.0% | 0.00% | – |
| Q4 2020 | $145,000 | +20.8% | 58,100 | 0.0% | 0.00% | – |
| Q3 2020 | $120,000 | -37.2% | 58,100 | -5.8% | 0.00% | – |
| Q2 2020 | $191,000 | +70.5% | 61,700 | +25.9% | 0.00% | – |
| Q1 2020 | $112,000 | -26.8% | 49,000 | +15.8% | 0.00% | – |
| Q4 2019 | $153,000 | +6.2% | 42,300 | 0.0% | 0.00% | – |
| Q3 2019 | $144,000 | -86.8% | 42,300 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $1,092,000 | +45.4% | 232,390 | +3.7% | 0.00% | – |
| Q1 2019 | $751,000 | +21.7% | 224,190 | -3.3% | 0.00% | – |
| Q4 2018 | $617,000 | -24.2% | 231,790 | +59.4% | 0.00% | -100.0% |
| Q3 2018 | $814,000 | +13.5% | 145,380 | +2.8% | 0.00% | – |
| Q2 2018 | $717,000 | -1.0% | 141,480 | +33.4% | 0.00% | -100.0% |
| Q1 2018 | $724,000 | +470.1% | 106,090 | +531.5% | 0.00% | – |
| Q4 2017 | $127,000 | +69.3% | 16,800 | +29.2% | 0.00% | – |
| Q3 2017 | $75,000 | +13.6% | 13,000 | 0.0% | 0.00% | – |
| Q2 2017 | $66,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 778,230 | $5,308,000 | 5.22% |
| BVF INC/IL | 3,592,549 | $24,501,000 | 2.48% |
| Prosight Management, LP | 563,763 | $3,845,000 | 2.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $5,456,000 | 0.83% |
| Virtus ETF Advisers LLC | 125,695 | $857,000 | 0.74% |
| EAM Investors, LLC | 521,460 | $3,556,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $14,236,000 | 0.55% |
| Orbimed Advisors | 5,550,000 | $37,851,000 | 0.47% |
| EAM Global Investors LLC | 125,635 | $857,000 | 0.44% |
| Schonfeld Strategic Advisors LLC | 830,637 | $5,665,000 | 0.42% |